Session Type
Meeting
Search Results for Encephalitis
Abstract Number: 709
SHM Converge 2023
Case Presentation: 62-year-old male admitted following new onset generalized tonic clonic seizure lasting 5-6 minutes witnessed by mother. Per EMS on scene, he was agitated and required ketamine and midazolam while on route to the hospital. Upon admission, he was hemodynamically stable with physical exam only remarkable for raised maculopapular rash extending from the left […]
Abstract Number: 710
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: A 64-year-old Caucasian male with hypertension and diabetes mellitus presented to the emergency room with confusion, ataxia, and urinary retention after a 10-day cruise to Aruba. During the cruise, he developed fever, diarrhea, and a rash. After returning home, he visited a local ED and was treated with ciprofloxacin and metronidazole for febrile […]
Abstract Number: 716
SHM Converge 2023
Case Presentation: Autoimmune encephalitides comprise a rapidly evolving group of immune-mediated disorders characterized by inflammation of the brain parenchyma. Patients with this disorder manifest a wide spectrum of neurological and psychiatric presentations developing over days to months. One sub-type is anti-NMDAR-encephalitis, which is characterized by complex neuropsychiatric features and the presence of IgG antibodies against […]
Abstract Number: 726
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: Human Herpes Virus 6 (HHV-6) is a member of the herpesviridae family. HHV-6 is the causative agent in roseola infantum, a usually mild and self-limiting childhood exanthem. HHV-6 is also associated with a variety of syndromes in recipients of hematopoietic stem cell transplantation (HSCT), including hepatitis, encephalitis, and bone marrow suppression. However, HHV-6 […]
Abstract Number: 727
SHM Converge 2024
Case Presentation: A 35-year-old woman with no significant medical history presented with severe headache, neck pain, photophobia, fevers, nausea, vomiting, and petechial rash for 5 days. She had recently attended a large outdoor wedding in rural Iowa. On exam her vital signs were within normal limits and neurologic exam was without focal deficits or meningeal […]
Abstract Number: 752
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Case Presentation: A 63 year old female with metastatic melanoma to brain and breast presented to the emergency department with altered mental status. She was disoriented to time and place and unable to follow commands. She had received two doses of immunotherapy with ipilimumab and nivolumab. Her last dose was administered two weeks prior. She […]
Abstract Number: 752
Hospital Medicine 2020, Virtual Competition
Case Presentation: A 69 year old man with history of Stage IV Mantle cell lymphoma on maintenance Rituximab presented to the emergency department with acute confusion and expressive aphasia. Patient was at his behavioral and functional baseline prior to this episode and there had not been any recent illnesses, medication changes or inciting events. Initial […]
Abstract Number: 756
SHM Converge 2023
Case Presentation: Case Presentation:A 36 year-old male with a history of HIV adequately controlled with Biktarvy and recent monkeypox infection presented with acute onset of rapidly ascending lower extremity paralysis. He presented to the ED for primary concern of severe left upper quadrant and back pain. He also noted bilateral lower extremity numbness below the […]
Abstract Number: 771
SHM Converge 2021
Case Presentation: Anti-NMDA Receptor Encephalitis is an uncommon diagnosis disguised behind the more common chief complaint of altered mentation. Although treatment options have been established for this disease, management of its behavioral manifestations remains complex. Here we discuss a 13-year-old female who presented with acute-onset altered mental status and atypical behavior. At symptom onset, a […]
Abstract Number: 792
SHM Converge 2024
Case Presentation: A 56-year-old female with stage IIB T2N0M0, grade 3, and triple negative breast cancer, was treated with lumpectomy and neoadjuvant chemoimmunotherapy (dose-dense doxorubicin and cyclophosphamide followed by carboplatin/paclitaxel/pembrolizumab). This resulted in near-complete remission. However, evidence of residual disease was found and she was started on pembrolizumab and capecitabine for 3 months. She presented […]